The Diagnostic Performance of a Single GeneXpert MTB/RIF Assay in an Intensified Tuberculosis Case Finding Survey among HIV-Infected Prisoners in Malaysia

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Al Darraji, Haider Abdulrazzaq Abed ^a   Razak, Humaira Abd ^a   Ng, Kee Peng ^a   Altice, Frederick L ^a,b,c   Kamarulzaman, Adeeba ^a,b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; RIFAMPICIN;

ACID FAST BACTERIUM; ADULT; ARTICLE; CASE FINDING; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; DRUG EFFECT; FEMALE; FLUORESCENCE MICROSCOPY; GOLD STANDARD; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ABUSE; LIQUID CULTURE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION; PREDICTIVE VALUE; PRISONER; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR;

ADULT; BACTERIOLOGICAL TECHNIQUES; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HIV INFECTIONS; HUMANS; MALAYSIA; MALE; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; PRISONERS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 84883638221     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073717     Document Type: Article

References (75)

1. World Health Organization (WHO) (2012) Global Tuberculosis Report 2012 Geneva: Elsevier.
2. Lönnroth K, Corbett E, Golub J, Uplekar M, Weil D, et al. (2013) Systematic screening for active tuberculosis: rationale, definitions and key considerations. Int J Tuberc Lung Dis 17: 289-298. doi:10.5588/ijtld.12.0797. PubMed: 23407219.
3. Maxmen A, (2013) Ahead of WHO meeting, experts clash over tuberculosis targets. Nat Med 19: 115. doi:10.1038/nm0213-115. PubMed: 23389590.
4. Lawn SD, Zumla AI, (2011) Tuberculosis. Lancet 378: 57-72. doi:10.1016/S0140-6736(10)62173-3. PubMed: 21420161.
5. Zumla A, Raviglione M, Hafner R, Von Reyn CF, (2013) Tuberculosis. N Engl J Med 368: 745-755. doi:10.1056/NEJMra1200894. PubMed: 23425167.
6. Corbett EL, Marston B, Churchyard GJ, De Cock KM, (2006) Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 367: 926-937. doi:10.1016/S0140-6736(06)68383-9. PubMed: 16546541.
7. Golub JE, Mohan CI, Comstock GW, Chaisson RE, (2005) Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis 9: 1183-1203. PubMed: 16333924.
8. Wood R, Middelkoop K, Myer L, Grant AD, Whitelaw A, et al. (2007) Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med 175: 87-93. doi:10.1164/rccm.200606-759OC. PubMed: 16973982.
9. Davis JL, Worodria W, Kisembo H, Metcalfe JZ, Cattamanchi A, et al. (2010) Clinical and radiographic factors do not accurately diagnose smear-negative tuberculosis in HIV-infected inpatients in Uganda: a cross-sectional study. PLOS ONE 5: e9859. doi:10.1371/journal.pone.0009859. PubMed: 20361038.
10. Mtei L, Matee M, Herfort O, Bakari M, Horsburgh CR, et al. (2005) High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin Infect Dis 40: 1500-1507. doi:10.1086/429825. PubMed: 15844073.
11. O'Grady J, Hoelscher M, Atun R, Bates M, Mwaba P, et al. (2011) Tuberculosis in prisons in sub-Saharan Africa--the need for improved health services, surveillance and control. Tuberculosis (Edinb, Scotland) 91: 173-178. doi:10.1016/j.tube.2010.12.002.
12. Getahun H, Gunneberg C, Sculier D, Verster A, Raviglione M, (2012) Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services. Current Opinion HIV Aids 7: 345-353. doi:10.1097/COH.0b013e328354bd44. PubMed: 22678489.
13. Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, et al. (2010) Tuberculosis incidence in prisons: a systematic review. PLOS Med 7: e1000381. PubMed: 21203587.
14. Vinkeles Melchers NVS, Van Elsland SL, Lange JMa, Borgdorff MW, Van den Hombergh J, (2013) State of Affairs of Tuberculosis in Prison Facilities: A Systematic Review of Screening Practices and Recommendations for Best TB Control. PLOS ONE 8: e53644. doi:10.1371/journal.pone.0053644. PubMed: 23372662.
15. Saunders DL, Olive DM, Wallace SB, Lacy D, Leyba R, et al. (2001) Tuberculosis screening in the federal prison system: an opportunity to treat and prevent tuberculosis in foreign-born populations. Public Health Rep (Washington, DC: 1974116:: 210-218. PubMed: 12034910.
16. Reid SE, Topp SM, Turnbull ER, Hatwiinda S, Harris JB, et al. (2012) Tuberculosis and HIV control in sub-Saharan African prisons: thinking outside the prison cell. J Infect Dis 205 (Suppl):: S265-S273. doi:10.1093/infdis/jis029. PubMed: 22448015.
17. Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, et al. (2011) Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLOS Med 8: e1000391.
18. Kranzer K, Houben RM, Glynn JR, Bekker L-G, Wood R, et al. (2010) Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. Lancet Infect Dis 10: 93-102. doi:10.1016/S1473-3099(09)70326-3. PubMed: 20113978.
19. Alvarez-Uria G, Azcona JM, Midde M, Naik PK, Reddy S, et al. (2012) Rapid Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in HIV-Infected Patients. Comparison of LED Fluorescent Microscopy and the GeneXpert MTB/RIF Assay in a District Hospital in India. Tuberculosis Res Treat: pp. 2012: Article ID 932862, 4 pages.
20. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, et al. (2010) Rapid Molecular Detection of Tuberculosis and Rifampin Resistance. N Engl J Med 363: 1005-1015. doi:10.1056/NEJMoa0907847. PubMed: 20825313.
21. Fournet N, Sanchez A, Massari V, Penna L, Natal S, et al. (2006) Development and evaluation of tuberculosis screening scores in Brazilian prisons. Public Health 120: 976-983. doi:10.1016/j.puhe.2006.06.004. PubMed: 16965796.
22. World Health Organization (WHO) (2000) Tuberculosis Control in Prisons: A Manual for Programme Managers. Geneva.
23. Steingart K, Sohn H, Schiller I, Kloda L, Boehme C, et al. (2013) Xpert® MTB/ RIF assay for pulmonary tuberculosis and rifampicin resistance in adults (Review). Cochrane Database of Systematic Reviews: Art. No: CD009593.
24. Chang K, Lu W, Wang J, Zhang K, Jia S, et al. (2012) Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect 64: 580-588. doi:10.1016/j.jinf.2012.02.012. PubMed: 22381459.
25. World Health Organization (WHO) (2011) Rapid Implementation of the Xpert MTB/ RIF diagnostic test: technical and operational "How-to"; practical considerations. Geneva.
26. Winetsky DE, Negoescu DM, DeMarchis EH, Almukhamedova O, Dooronbekova A, et al. (2012) Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis. PLOS Med 9: e1001348. PubMed: 23209384.
27. Reid SE, Topp SM, Turnbull ER, Hatwiinda S, Harris JB, et al. (2012) Tuberculosis and HIV control in sub-Saharan African prisons: "thinking outside the prison cell". J Infect Dis 205 (Suppl):: S265-S273. doi:10.1093/infdis/jis029. PubMed: 22448015.
28. Iyawoo K, (2004) Tuberculosis in Malaysia: problems and prospect of treatment and control. Tuberculosis 84: 4-7. doi:10.1016/j.tube.2003.08.014. PubMed: 14670340.
29. Walmsley R, (2011) World Prison Population List (ninth edition).
30. Choi P, Kavasery R, Desai MM, Govindasamy S, Kamarulzaman A, et al. (2010) Prevalence and correlates of community re-entry challenges faced by HIV-infected male prisoners in Malaysia. Int J STD AIDS 21: 416-423. doi:10.1258/ijsa.2009.009180. PubMed: 20606222.
31. SURUHANJAYA HAK ASASI MANUSIA MALAYSIA (2008). The State Prisons Immigration Detention Cent Malays: pp. 2007-2008. Available: http://www.suhakam.org.my/c/document_library/get_file?p_l_id=10408&folderId=236834&name=DLFE-7802.pdf.
32. World Health Organization (WHO) (2006) Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. Recommendations for HIV-prevalent and resource-constrained settings. Geneva.
33. World Health Organization (WHO) (2011) Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource- constrained settings. Geneva.
34. Dean AG, Sullivan KM, Soe MM, (2011) OpenEpi: Open Source Epidemiologic Statistics for Public Health. Available: www.OpenEpi.com. Accessed 3 March 2013.
35. Kufa T, Mngomezulu V, Charalambous S, Hanifa Y, Fielding K, et al. (2012) Undiagnosed tuberculosis among HIV clinic attendees: association with antiretroviral therapy and implications for intensified case finding, isoniazid preventive therapy, and infection control. J Acquir Immune Defic Syndr, 60e22-8 (1999) 60: e22-8. PubMed: 22627184.
36. Theron G, Peter J, Van Zyl-Smit R, Mishra H, Streicher E, et al. (2011) Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 184: 132-140. doi:10.1164/rccm.201101-0056OC. PubMed: 21493734.
37. Ntinginya EN, Squire SB, Millington Ka, Mtafya B, Saathoff E, et al. (2012) Performance of the Xpert® MTB/RIF assay in an active case-finding strategy: a pilot study from Tanzania. Int J Tuberc Lung Dis 16: 1468-1470. doi:10.5588/ijtld.12.0127. PubMed: 22964006.
38. Kirwan DE, Cárdenas MK, Gilman RH, (2012) Rapid implementation of new TB diagnostic tests: is it too soon for a global roll-out of Xpert MTB/RIF? Am J Trop Med Hyg 87: 197-201. doi:10.4269/ajtmh.2012.12-0107. PubMed: 22855746.
39. Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, et al. (2011) Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLOS Med 8: e1001067. PubMed: 21818180.
40. Laserson KF, Wells CD, (2007) Reaching the targets for tuberculosis control: the impact of HIV. Bull World Health Organ 85: 377-381. doi:10.2471/BLT.06.035329. PubMed: 17639223.
41. Rachow A, Zumla A, Heinrich N, Rojas-Ponce G, Mtafya B, et al. (2011) Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay-a clinical validation study. PLOS ONE 6: e20458. doi:10.1371/journal.pone.0020458. PubMed: 21738575.
42. Cattamanchi A, Dowdy DW, Davis JL, Worodria W, Yoo S, et al. (2009) Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis. BMC Infect Dis 9: 53. doi:10.1186/1471-2334-9-53. PubMed: 19419537.
43. Swaminathan S, Padmapriyadarsini C, Narendran G, (2010) HIV-associated tuberculosis: clinical update. Clin Infect Dis 50: 1377-1386. doi:10.1086/652147. PubMed: 20388036.
44. Gupta RK, Lawn SD, Bekker LG, Caldwell J, Kaplan R, et al. (2013) Impact of human immunodeficiency virus and CD4 count on tuberculosis diagnosis: analysis of city-wide data from Cape Town, South Africa. Int J Tuberc Lung Dis 17: 1014-1022. doi:10.5588/ijtld.13.0032. PubMed: 23827024.
45. Carriquiry G, Otero L, González-Lagos E, Zamudio C, Sánchez E, et al. (2012) A diagnostic accuracy study of Xpert®MTB/RIF in HIV-positive patients with high clinical suspicion of pulmonary tuberculosis in Lima, Peru. PLOS ONE 7: e44626. doi:10.1371/journal.pone.0044626. PubMed: 22970271.
46. Lawn SD, Kerkhoff AD, Vogt M, Ghebrekristos Y, Whitelaw A, et al. (2012) Characteristics and early outcomes of patients with Xpert MTB/RIF-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapy. Clin Infect Dis 54: 1071-1079. doi:10.1093/cid/cir1039. PubMed: 22318975.
47. Schnippel K, Meyer-Rath G, Long L, Stevens WS, Sanne I, et al. (2014) Diagnosing Xpert MTB/ RIF-negative TB: Impact and cost of alternative algorithms for South Africa. S Afr Med J 103: 101-106.
48. Theron G, Pooran A, Peter J, Van Zyl-Smit R, Kumar Mishra H, et al. (2012) Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? Eur Respir J 40: 161-168. doi:10.1183/09031936.00145511. PubMed: 22075479.
49. Menzies, Na, Cohen T, Lin H-H, Murray M, Salomon J a (2012) Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLOS Med 9: e1001347. PubMed: 23185139.
50. Lin H-H, Dowdy D, Dye C, Murray M, Cohen T, (2012) The impact of new tuberculosis diagnostics on transmission: why context matters. Bull World Health Organ 90: 739-747A. doi:10.2471/BLT.11.101436. PubMed: 23109741.
51. Sanchez, a, Gerhardt G, Natal S, Capone D, Espinola A,et al (2005) Prevalence of pulmonary tuberculosis and comparative evaluation of screening strategies in a Brazilian prison. Int J Tuberc Lung Dis 9: 633-639. PubMed: 15971390.
52. Legrand J, Sanchez A, Le Pont F, Camacho L, Larouze B, (2008) Modeling the impact of tuberculosis control strategies in highly endemic overcrowded prisons. PLOS ONE 3: e2100. doi:10.1371/journal.pone.0002100. PubMed: 18461123.
53. Lawn SD, Harries AD, Meintjes G, Getahun H, Havlir DV, et al. (2012) Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa. AIDS Lond Engl 26: 2121-2133. doi:10.1097/QAD.0b013e3283565dd1. PubMed: 22695302.
54. Ngadaya ES, Mfinanga GS, Wandwalo ER, Morkve O, (2009) Detection of pulmonary tuberculosis among patients with cough attending outpatient departments in Dar Es Salaam, Tanzania: does duration of cough matter? BMC Health Serv Res 9: 112. doi:10.1186/1472-6963-9-112. PubMed: 19570233.
55. Nguyen DTM, Hung NQ, Giang LT, Dung NH, Lan NTN, et al. (2011) Improving the diagnosis of pulmonary tuberculosis in HIV-infected individuals in Ho Chi Minh City, Viet Nam. Int J Tuberc Lung Dis 15: 1528-1534. doi:10.5588/ijtld.10.0777. PubMed: 22008768.
56. Oni T, Burke R, Tsekela R, Bangani N, Seldon R, et al. (2011) High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening. Thorax 66: 669-673. doi:10.1136/thx.2011.160168. PubMed: 21632522.
57. Rangaka MX, Wilkinson RJ, Glynn JR, Boulle A, Van Cutsem G, et al. (2012) Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic. Clin Infect Dis 55: 1698-1706. doi:10.1093/cid/cis775. PubMed: 22955441.
58. Demers A-M, Verver S, Boulle A, Warren R, Van Helden P, et al. (2012) High yield of culture-based diagnosis in a TB-endemic setting. BMC Infect Dis 12: 218. doi:10.1186/1471-2334-12-218. PubMed: 22978323.
59. Stead WW, (1978) Undetected tuberculosis in prison. Source of infection for community at large. JAMA 240: 2544-2547. doi:10.1001/jama.240.23.2544. PubMed: 712956.
60. Noeske J, Ndi N, Mbondi S, (2011) Controlling tuberculosis in prisons against confinement conditions: a lost case? Experience Cameroon Int J Tuberc Lung Dis 15: 223-227.
61. Fernandez de la Hoz K, Iñigo J, Fernandez-Martín JI, Arce A, Alonso-Sanz M, et al. (2001) The influence of HIV infection and imprisonment on dissemination of Mycobacterium tuberculosis in a large Spanish city. Int J Tuberc Lung Dis 5: 696-702. PubMed: 11495258.
62. Sosa LE, Lobato MN, Condren T, Williams MN, Hadler JL, (2008) Outbreak of tuberculosis in a correctional facility. Int J Tuberc Lung Dis 12: 689-691. PubMed: 18492339.
63. Portugal I, Covas MJ, Brum L, Viveiros M, Ferrinho P, et al. (1999) Outbreak of multiple drug-resistant tuberculosis in Lisbon: detection by restriction fragment length polymorphism analysis. Int J Tuberc Lung Dis 3: 207-213. PubMed: 10094321.
64. Ijaz K, Yang Z, Templeton G, Stead WW, Bates JH, et al. (2004) Persistence of a strain of Mycobacterium tuberculosis in a prison system. Int J Tuberc Lung Dis 8: 994-1000. PubMed: 15305483.
65. Van Rie A, Page-Shipp L, Scott L, Sanne I, Stevens W, (2010) Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? Expert Rev Mol Diagn 10: 937-946. doi:10.1586/erm.10.67. PubMed: 20964612.
66. Reid MJa, Shah NS, (2009) Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis 9: 173-184. doi:10.1016/S1473-3099(09)70043-X. PubMed: 19246021.
67. Al-Darraji HAA, Kamarulzaman A, Altice FL, (2012) Isoniazid preventive therapy in correctional facilities: a systematic review. Int J Tuberc Lung Dis 16: 871-879. doi:10.5588/ijtld.11.0447. PubMed: 22410101.
68. Deiss RG, Rodwell TC, Garfein RS, (2009) Tuberculosis and illicit drug use: review and update. Clin Infect Dis 48: 72-82. doi:10.1086/594126. PubMed: 19046064.
69. Wong K, Gan D, Al-Darraji H, Fu J, Loeliger K, et al. (2012) High prevalence of latent tuberculosis infection among attendees of a Malaysian Drug Rehabilitation Centre (Oral Presentation). 43rd Union World Conference on Lung Health, Kuala Lumpur.
70. Margolis B, Al-Darraji HAA, Wickersham JA, Kamarulzaman A, Altice FL, (2013) Prevalence of Tuberculosis Symptoms and Latent Tuberculosis Infection among Prisoners in Northeastern Malaysia. Int J Tuberc Lung Dis (In press).
71. Sylla L, Bruce RD, Kamarulzaman A, Altice FL, (2007) Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy 18: 306-312. doi:10.1016/j.drugpo.2007.03.001. PubMed: 17689379.
72. World Health Organization (WHO) (2008) Policy Guidelines for Collaborative TB and HIV Services for Injecting and Other Drug Users: An Integrated Approach. Geneva.
73. Fu JJ, Bazazi AR, Altice FL, Mohamed MN, Kamarulzaman A, (2012) Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers. PLOS ONE 7: e44249. doi:10.1371/journal.pone.0044249. PubMed: 23028508.
74. Stuckler D, Basu S, McKee M, King L, (2008) Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries. Proc Natl Acad Sci U S A 105: 13280-13285. doi:10.1073/pnas.0801200105. PubMed: 18728189.
75. Jittimanee SX, Ngamtrairai N, White MC, Jittimanee S, (2007) A prevalence survey for smear-positive tuberculosis in Thai prisons. Int J Tuberc Lung Dis 11: 556-561. PubMed: 17439681.